Breast lumps differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 105: | Line 105: | ||
* Imbalance between [[estrogen]] and [[progesterone]] | * Imbalance between [[estrogen]] and [[progesterone]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align=" | | align="left" style="background:#F5F5F5;" left" | | ||
* No increased risk of [[malignancy]] | * No increased risk of [[malignancy]] | ||
* Slightly increased risk of [[malignancy]] in presence of positive [[familial history]] of [[breast cancer]] | * Slightly increased risk of [[malignancy]] in presence of positive [[familial history]] of [[breast cancer]] | ||
Line 123: | Line 123: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Nonproliferative breast lesions | * Nonproliferative breast lesions | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
Line 166: | Line 166: | ||
| align="center" style="background:#F5F5F5;" |[[Obstruction]] of periareolar [[Glands of Montgomery|glands of montgomery]] | | align="center" style="background:#F5F5F5;" |[[Obstruction]] of periareolar [[Glands of Montgomery|glands of montgomery]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* No increased risk of [[malignancy]] | * No increased risk of [[malignancy]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Most common in age of 10-20 years old | * Most common in age of 10-20 years old | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
Line 183: | Line 183: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Acute]] [[inflammation]] due to [[obstruction]] of the [[Montgomery's glands|Montgomery's gland]] | * [[Acute]] [[inflammation]] due to [[obstruction]] of the [[Montgomery's glands|Montgomery's gland]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Single [[cystic]] lesion in retroareolar area | * Single [[cystic]] lesion in retroareolar area | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Ultrasound]] | * [[Ultrasound]] | ||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
Line 195: | Line 195: | ||
* Unknown | * Unknown | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Coexisting [[malignancy]] can occur | * Coexisting [[malignancy]] can occur | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Common in women older than 35 years old | * Common in women older than 35 years old | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
Line 282: | Line 282: | ||
* [[Fever]] | * [[Fever]] | ||
* [[Nipple]] [[retraction]] | * [[Nipple]] [[retraction]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
| align="left" style="background:#F5F5F5;" |[[Breast]] [[parenchyma]] [[inflammation]]: | | align="left" style="background:#F5F5F5;" |[[Breast]] [[parenchyma]] [[inflammation]]: | ||
Line 420: | Line 420: | ||
* A mass with or without [[calcification]] | * A mass with or without [[calcification]] | ||
* [[stromal]] reaction | * [[stromal]] reaction | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Mammography]] | * [[Mammography]] | ||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
Line 442: | Line 442: | ||
* Well-defined | * Well-defined | ||
* Firm mass | * Firm mass | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
Line 466: | Line 465: | ||
* Grow aggressively | * Grow aggressively | ||
* Classify in [[benign]], [[borderline]], and [[malignant]] groups | * Classify in [[benign]], [[borderline]], and [[malignant]] groups | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
Line 586: | Line 584: | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* Common between age of 40-60 years old | * Common between age of 40-60 years old | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* [[Benign]] tumors | * [[Benign]] tumors | ||
Line 617: | Line 614: | ||
! align="left" style="background:#F5F5F5;" | | ! align="left" style="background:#F5F5F5;" | | ||
* Small risk of [[malignancy]] | * Small risk of [[malignancy]] | ||
! align=" | ! align="left" style="background:#F5F5F5;" | | ||
* Result in repeating pain during mensturation | * Result in repeating pain during mensturation | ||
! align="left" style="background:#F5F5F5;" | | ! align="left" style="background:#F5F5F5;" | | ||
* May present as a mass or incidental finding on [[mammogram]] | * May present as a mass or incidental finding on [[mammogram]] | ||
* No treatment is needed | * No treatment is needed | ||
! align="center" style="background:#F5F5F5;" |± | ! align="center" style="background:#F5F5F5;" |± | ||
! align="center" style="background:#F5F5F5;" |+ | ! align="center" style="background:#F5F5F5;" |+ | ||
Line 682: | Line 678: | ||
* [[Radiation therapy]] | * [[Radiation therapy]] | ||
* [[Trauma]] | * [[Trauma]] | ||
! align="center" style="background:#F5F5F5;" |+ | ! align="center" style="background:#F5F5F5;" |+ | ||
! align="center" style="background:#F5F5F5;" |– | ! align="center" style="background:#F5F5F5;" |– | ||
Line 769: | Line 764: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Benign breast tissue swelling among men and boys around [[puberty]] | * Benign breast tissue swelling among men and boys around [[puberty]] | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
Line 818: | Line 813: | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* [[Idiopathic]] [[systemic]] [[granulomatous]] disorder | * [[Idiopathic]] [[systemic]] [[granulomatous]] disorder | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Irregular, | * Irregular, | ||
* Ill-defined, | * Ill-defined, |
Revision as of 17:58, 21 January 2019
Breast lumps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Breast lumps differential diagnosis On the Web |
American Roentgen Ray Society Images of Breast lumps differential diagnosis |
Risk calculators and risk factors for Breast lumps differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Breast lumps must be differentiated from other diseases such as malignancy, cysts, inflammation and non-inflammatory solid lumps. Breast symptoms such as nipple discharge and mastalgia require assessment as well.
Differentiating Breast lumps from other Diseases
Differential diagnosis of breast lumps include:
Diseases | Etiology | Benign | Malignant | Clinical manifestation | Paraclinical findings | Gold standard diagnosis | Associated findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Lab findings | Histopathology | Imaging | ||||||||||||
Mass | Mastalgia | Nipple discharge | Breast exam | Skin changes | LAP | Others | ||||||||||||
Fibroadenoma[1] |
|
+ |
|
+ | ± | – |
|
– | – | NA | Nl |
|
|
NA | ||||
Breast cyst[2] |
|
+ |
|
|
|
+ | ± | – |
|
– | – | NA | Nl |
|
NA | |||
Fibrocystic change[3] |
|
+ |
|
|
|
+ | + | ± |
|
– | – | NA | Nl |
|
|
NA | ||
Galactocele[4] |
|
+ |
|
|
+ | ± | ± |
|
– | – | NA | Nl |
|
|
NA | |||
Cysts of montgomery[5] | Obstruction of periareolar glands of montgomery | + |
|
|
|
+ | ± | ± |
|
± | – | NA | Nl |
|
|
NA | ||
Hamartoma[6] |
|
+ |
|
|
|
± | – | – |
|
± | – | NA | Nl |
|
|
NA | ||
Breast abscess[7] | + |
|
|
+ | + | – |
|
+ | – |
|
|
|
NA | |||||
Mastitis[8][9] | + |
|
|
drainage |
± | + | ± |
|
+ | – | Breast parenchyma inflammation: |
|
NA | |||||
Diseases | Etiology | Benign | Malignant | Demography | History | Mass | Pain | Nipple discharge | Breast exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Breast carcinoma[10][11][12] | – | + |
|
|
+ | – | ± |
|
± | ± |
|
Nl |
|
| ||||
Ductal carcinoma in situ (DCIS)[13][14] | – | + |
|
|
± | – | ± |
|
– | – | NA | Nl |
|
|
NA | |||
Microinvasive breast cancer[15] |
|
– |
+ |
|
|
+ | – | ± |
|
– | ± | NA | Nl |
|
|
NA | ||
Breast sarcoma[16] |
|
– | + |
|
|
+ | – | – |
|
± | – | NA | Nl |
|
|
NA | ||
Phyllodes tumor[17][18] |
|
± | ± |
|
|
± | – | – |
|
– | – | NA | Nl |
|
|
NA | ||
Lymphoma[19][20] | – | + |
|
|
+ | – | – |
|
– | ± | NA | Nl |
|
|
|
NA | ||
Duct ectasia[21] |
|
+ | – |
|
|
± | ± | ± |
|
– | – | NA | Nl |
|
|
NA | ||
Intraductal papilloma[22] |
|
+ | – |
|
+ | ± | ± |
|
– | – | NA | Nl |
|
|
|
NA | ||
Lipoma[23] |
|
+ | – |
|
|
+ | – | – |
|
– | – | NA | Nl |
|
|
NA | ||
Sclerosing adenosis[24][25] |
|
+ |
|
|
|
± | + | – |
|
± | – | NA | Nl |
|
|
NA | ||
Pseudoangiomatous stromal hyperplasia[26][27] |
|
+ | – |
|
|
+ | – | – |
|
– | – | NA | Nl |
|
|
NA | ||
Mondor's disease[28][29] | Complication of: | + | – |
|
+ | + | – |
|
+ | – | NA | Nl | Thrombophlebitis of superficial veins of the breast |
|
|
NA | ||
Diseases | Etiology | Benign | Malignant | Demography | History | Mass | Pain | Nipple discharge | Breast exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Diabetic mastopathy[30] |
|
+ | – |
|
|
+ | – | – |
|
– | – | NA | Nl |
|
|
|
NA | |
Gynecomastia[31][32] |
|
+ | – |
|
|
+ | ± | ± |
|
– | – | NA | Nl |
|
NA | |||
Sarcoidosis[33] |
|
+ | – |
|
|
+ | – | – |
|
– | – | NA | Nl |
|
|
NA | ||
Fat necrosis[34] |
|
+ | – |
|
+ | ± | – |
|
– | – | NA | Nl |
|
|
NA |
References
- ↑ Pinto, Joana; Aguiar, Ana Teresa; Duarte, Hálio; Vilaverde, Filipa; Rodrigues, Ângelo; Krug, José Luís (2014). "Simple and Complex Fibroadenomas". Journal of Ultrasound in Medicine. 33 (3): 415–419. doi:10.7863/ultra.33.3.415. ISSN 0278-4297.
- ↑ Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V; et al. (2005). "Benign breast diseases". J Mammary Gland Biol Neoplasia. 10 (4): 325–35. doi:10.1007/s10911-006-9006-4. PMID 16900392.
- ↑ Templeman C, Hertweck SP (2000). "Breast disorders in the pediatric and adolescent patient". Obstet Gynecol Clin North Am. 27 (1): 19–34. PMID 10693180.
- ↑ Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P; et al. (2007). "Radiologic evaluation of breast disorders related to pregnancy and lactation". Radiographics. 27 Suppl 1: S101–24. doi:10.1148/rg.27si075505. PMID 18180221.
- ↑ De Silva NK, Brandt ML (2006). "Disorders of the breast in children and adolescents, Part 2: breast masses". J Pediatr Adolesc Gynecol. 19 (6): 415–8. doi:10.1016/j.jpag.2006.09.002. PMID 17174833.
- ↑ Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC; et al. (2002). "Hamartoma of the breast: a clinicopathological review". J Clin Pathol. 55 (12): 951–4. PMC 1769817. PMID 12461066.
- ↑ Dixon JM (2007). "Breast abscess". Br J Hosp Med (Lond). 68 (6): 315–20. doi:10.12968/hmed.2007.68.6.23574. PMID 17639835.
- ↑ Dixon JM, Ravisekar O, Chetty U, Anderson TJ (1996). "Periductal mastitis and duct ectasia: different conditions with different aetiologies". Br J Surg. 83 (6): 820–2. PMID 8696751.
- ↑ Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists (2007). "ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects". Obstet Gynecol. 109 (2 Pt 1): 479–80. PMID 17267864.
- ↑ Siegel RL, Miller KD, Jemal A (January 2018). "Cancer statistics, 2018". CA Cancer J Clin. 68 (1): 7–30. doi:10.3322/caac.21442. PMID 29313949.
- ↑ Li CI, Uribe DJ, Daling JR (October 2005). "Clinical characteristics of different histologic types of breast cancer". Br. J. Cancer. 93 (9): 1046–52. doi:10.1038/sj.bjc.6602787. PMC 2361680. PMID 16175185.
- ↑ Parise CA, Bauer KR, Brown MM, Caggiano V (2009). "Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004". Breast J. 15 (6): 593–602. doi:10.1111/j.1524-4741.2009.00822.x. PMID 19764994.
- ↑ Virnig BA, Tuttle TM, Shamliyan T, Kane RL (February 2010). "Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes". J. Natl. Cancer Inst. 102 (3): 170–8. doi:10.1093/jnci/djp482. PMID 20071685.
- ↑ Brinton LA, Sherman ME, Carreon JD, Anderson WF (November 2008). "Recent trends in breast cancer among younger women in the United States". J. Natl. Cancer Inst. 100 (22): 1643–8. doi:10.1093/jnci/djn344. PMC 2720764. PMID 19001605.
- ↑ Sue GR, Lannin DR, Killelea B, Chagpar AB (October 2013). "Predictors of microinvasion and its prognostic role in ductal carcinoma in situ". Am. J. Surg. 206 (4): 478–81. doi:10.1016/j.amjsurg.2013.01.039. PMID 23791403.
- ↑ Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT (April 2012). "Imaging features of primary breast sarcoma". AJR Am J Roentgenol. 198 (4): W386–93. doi:10.2214/AJR.11.7341. PMID 22451578.
- ↑ Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA (April 2000). "Phyllodes tumors of the breast: a review of 32 cases". Am Surg. 66 (4): 360–6. PMID 10776873.
- ↑ Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK (October 2000). "Primary treatment of cystosarcoma phyllodes of the breast". Cancer. 89 (7): 1502–11. PMID 11013364.
- ↑ Brogi E, Harris NL (June 1999). "Lymphomas of the breast: pathology and clinical behavior". Semin. Oncol. 26 (3): 357–64. PMID 10375092.
- ↑ Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D (2000). "Primary breast lymphomas--a retrospective analysis of twelve cases". Acta Oncol. 39 (2): 135–9. PMID 10859001.
- ↑ Schwartz GF (June 1982). "Benign neoplasms and "inflammations" of the breast". Clin Obstet Gynecol. 25 (2): 373–85. PMID 6286199.
- ↑ Wen X, Cheng W (January 2013). "Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors". Ann. Surg. Oncol. 20 (1): 94–101. doi:10.1245/s10434-012-2590-1. PMID 22878621.
- ↑ Guray M, Sahin AA (May 2006). "Benign breast diseases: classification, diagnosis, and management". Oncologist. 11 (5): 435–49. doi:10.1634/theoncologist.11-5-435. PMID 16720843.
- ↑ Jensen RA, Page DL, Dupont WD, Rogers LW (1989). "Invasive breast cancer risk in women with sclerosing adenosis". Cancer. 64 (10): 1977–83. PMID 2804888.
- ↑ Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004). "Lower-category benign breast disease and the risk of invasive breast cancer". J Natl Cancer Inst. 96 (8): 616–20. PMID 15100339.
- ↑ Celliers L, Wong DD, Bourke A (2010). "Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features". Clin Radiol. 65 (2): 145–9. doi:10.1016/j.crad.2009.10.003. PMID 20103437.
- ↑ Salvador R, Lirola JL, Domínguez R, López M, Risueño N (2004). "Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients". Breast. 13 (5): 431–5. doi:10.1016/j.breast.2003.10.011. PMID 15454202.
- ↑ Becker L, McCurdy LI, Taves DH (2001). "Superficial thrombophlebitis of the breast (Mondor's disease)". Can Assoc Radiol J. 52 (3): 193–5. PMID 11436415.
- ↑ Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A (1992). "Mondor's disease and breast cancer". Cancer. 69 (9): 2267–70. PMID 1562972.
- ↑ Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB (2002). ""Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes". Diabetes Care. 25 (1): 121–6. PMID 11772912.
- ↑ Draghi F, Tarantino CC, Madonia L, Ferrozzi G (2011). "Ultrasonography of the male breast". J Ultrasound. 14 (3): 122–9. doi:10.1016/j.jus.2011.06.004. PMC 3558246. PMID 23397020.
- ↑ Braunstein GD (2007). "Clinical practice. Gynecomastia". N Engl J Med. 357 (12): 1229–37. doi:10.1056/NEJMcp070677. PMID 17881754.
- ↑ Lower EE, Hawkins HH, Baughman RP (2001). "Breast disease in sarcoidosis". Sarcoidosis Vasc Diffuse Lung Dis. 18 (3): 301–6. PMID 11587103.
- ↑ Soo MS, Kornguth PJ, Hertzberg BS (1998). "Fat necrosis in the breast: sonographic features". Radiology. 206 (1): 261–9. doi:10.1148/radiology.206.1.9423681. PMID 9423681.